SCHEDULE: Catheter Precision Discloses 7.5% Stake in Volato Group

Catheter Precision, Inc. has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Volato Group, Inc. following a private placement.

Summary

• Catheter Precision, Inc. acquired 2,941,176 shares of Volato Group, Inc. common stock.
• The acquisition represents a 7.5% beneficial ownership stake in the issuer.
• The shares were purchased pursuant to a Securities Purchase Agreement dated June 7, 2026.
• The transaction closed on June 18, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming a capital injection via private placement without signaling a change in corporate control.

Positives

• The acquisition indicates a strategic investment by Catheter Precision in Volato Group.
• The filing confirms the completion of a private placement transaction, providing capital to the issuer.

Negatives

• The filing notes that the shares were acquired for investment purposes, explicitly stating they are not held for the purpose of changing or influencing control of the issuer.

Risks

• The investment is subject to the general market risks associated with Volato Group's common stock performance.

Future Outlook

The filing does not provide specific forward-looking guidance regarding the issuer's operations, but confirms the reporting person's passive investment status.

Management Comments

• The reporting person certifies that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this filing represents a standard disclosure of significant shareholding following a private placement, common in small-cap equity financing rounds.

Comparison to Industry Standards

• The filing adheres to standard SEC Schedule 13G reporting requirements for passive investors acquiring more than 5% of a public company's equity.

Stakeholder Impact

• Existing shareholders may experience dilution due to the issuance of new shares in the private placement.

Next Steps

• Ongoing monitoring of Volato Group's share price and future regulatory filings.

Key Dates

Keywords

Volato Group, Catheter Precision, Schedule 13G, Beneficial Ownership, Private Placement, SOAR